Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Public ClinicalTrials.gov record NCT02013622. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Protocol 331-13-006: An Exploratory, Multicenter, Open-label, Monotherapy, Flexible-dose Brexpiprazole (OPC 34712) Trial in Adults With Early Episode Schizophrenia
Study identification
- NCT ID
- NCT02013622
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Industry
- Enrollment
- 49 participants
Conditions and interventions
Conditions
Interventions
- Brexpiprazole Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 35 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2013
- Primary completion
- Aug 31, 2014
- Completion
- Sep 30, 2014
- Last update posted
- Mar 28, 2016
2013 – 2014
United States locations
- U.S. sites
- 22
- U.S. states
- 9
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Cerritos | California | 90703 | — |
| Not listed | Chula Vista | California | 92105 | — |
| Not listed | Costa Mesa | California | 92626 | — |
| Not listed | Long Beach | California | 90806 | — |
| Not listed | Oakland | California | 94612 | — |
| Not listed | Oceanside | California | 92056 | — |
| Not listed | Pico Rivera | California | 90660 | — |
| Not listed | Riverside | California | 92506 | — |
| Not listed | San Diego | California | 92102 | — |
| Not listed | San Diego | California | 92123 | — |
| Not listed | Santa Ana | California | 92705 | — |
| Not listed | Torrance | California | 90502 | — |
| Not listed | Fort Lauderdale | Florida | 33334 | — |
| Not listed | Atlanta | Georgia | 30308 | — |
| Not listed | Hoffman Estates | Illinois | 60169 | — |
| Not listed | Lake Charles | Louisiana | 70629 | — |
| Not listed | Rochester | New York | 14618 | — |
| Not listed | Philadelphia | Pennsylvania | 19139 | — |
| Not listed | Memphis | Tennessee | 38119 | — |
| Not listed | Dallas | Texas | 75231 | — |
| Not listed | Dallas | Texas | 75243 | — |
| Not listed | Houston | Texas | 77007 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02013622, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 28, 2016 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02013622 live on ClinicalTrials.gov.